- $14.70bn
- $17.00bn
- $3.68bn
- 80
- 34
- 89
- 75
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,319 | 1,377 | 1,417 | 1,734 | 3,680 |
Cost of Revenue | |||||
Gross Profit | 673 | 762 | 822 | 957 | 1,778 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 1,095 | 1,114 | 1,177 | 1,279 | 3,208 |
Operating Profit | 223 | 263 | 240 | 455 | 471 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 191 | 236 | 205 | 406 | 282 |
Provision for Income Taxes | |||||
Net Income After Taxes | 149 | 178 | 152 | 320 | 206 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 149 | 170 | 152 | 320 | 207 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 149 | 170 | 152 | 320 | 175 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.36 | 1.64 | 1.55 | 1.95 | 2.02 |
Dividends per Share | |||||
Special Dividends per Share |